NextCure, Inc. Common Stock NXTC
$6.65
-13.75%
at last close
Analyst Consensus
- Consensus Rating
- Buy (2 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $21.50
- Implied Upside
- +223.3%
- Price Target Range
- $18.00 – $25.00
- Analysts (12 mo)
- 2
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-05-11 | LUCID CAPITAL MARKETSChristopher Liu |
Initiates coverage on | Buy | $25 |
| 2025-11-07 | Ladenburg ThalmannKevin DeGeeter |
Upgrades | Neutral → Buy | $18 |
| 2025-07-15 | Piper SandlerEdward Tenthoff |
Maintains | Overweight | $36 → $15 |
| 2025-07-01 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $36 |
| 2025-03-17 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $3 |
| 2025-03-07 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $4 → $3 |
| 2024-11-11 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $8 → $4 |
| 2024-08-02 | NeedhamGil Blum |
Reiterates | Buy | $4 |
| 2024-06-03 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $8 |
| 2024-05-31 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $8 |
| 2024-05-03 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $8 |
| 2024-05-03 | NeedhamGil Blum |
Reiterates | Buy | $4 |
| 2024-03-22 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $5 → $8 |
| 2024-03-20 | NeedhamGil Blum |
Maintains | Buy | $4 |
| 2023-12-14 | NeedhamGil Blum |
Maintains | Buy | $6 → $4 |
| 2023-08-08 | HC Wainwright & Co.Emily Bodnar |
Initiates coverage on | Buy | $7 |
| 2023-08-04 | NeedhamGil Blum |
Reiterates | Buy | $6 |
| 2023-05-05 | NeedhamGil Blum |
Reiterates | Buy | $6 |
| 2023-03-03 | NeedhamGil Blum |
Reiterates | Buy | $6 |
| 2022-11-04 | Ladenburg ThalmannAydin Huseynov |
Downgrades | Buy → Neutral | — |
| 2022-11-04 | NeedhamGil Blum |
Maintains | Buy | $12 → $6 |
| 2022-11-04 | Piper SandlerEdward Tenthoff |
Maintains | Overweight | $13 → $6 |
| 2022-08-23 | Truist SecuritiesAsthika Goonewardene |
Maintains | Buy | $19 → $15 |
| 2022-05-23 | Piper SandlerEdward Tenthoff |
Maintains | Overweight | $21 → $13 |
| 2022-03-01 | Ladenburg ThalmannAydin Huseynov |
Initiates coverage on | Buy | $16 |
| 2021-11-05 | NeedhamGil Blum |
Maintains | Buy | $30 → $14 |
| 2021-03-05 | Truist SecuritiesAsthika Goonewardene |
Upgrades | Hold → Buy | $13 → $19 |
| 2021-01-15 | B of A Securities |
Downgrades | Neutral → Underperform | $13 → $10 |
| 2020-07-16 | BenchmarkAydin Huseynov |
Upgrades | Hold → Buy | $17 |
| 2020-07-14 | BTIG |
Maintains | Buy | $61 → $27 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $6.65
- Market Cap
- $35.29 million
- 52-Week Range
- $1.55 – $15.74
- Average Volume
- 4.36 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.